Next Article in Journal
Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update
Next Article in Special Issue
Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of Leishmania major-Induced Leishmaniasis: In Silico and In Vitro Studies
Previous Article in Journal
Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review
Previous Article in Special Issue
Antitrypanosomal Activity of Anthriscus Nemorosa Essential Oils and Combinations of Their Main Constituents
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Novel Formula of Antiprotozoal Mixtures

1
Department of Food Chemistry and Biocatalysis, Wrocław University of Environmental and Life Sciences, ul. C.K. Norwida 25, 50-375 Wrocław, Poland
2
AdiFeed Sp. z o.o., Opaczewska, 02-201 Warsaw, Poland
3
Laboratory of Industrial and Experimental Biology, Institute for Health and Economics, Carpathian State College in Krosno, Rynek, 38-400 Krosno, Poland
*
Author to whom correspondence should be addressed.
Antibiotics 2022, 11(7), 913; https://doi.org/10.3390/antibiotics11070913
Submission received: 2 June 2022 / Revised: 29 June 2022 / Accepted: 2 July 2022 / Published: 7 July 2022
(This article belongs to the Special Issue Antiprotozoal Activity of Natural Products)

Abstract

:
Antimicrobial resistance (AMR) is becoming more common in both bacteria and pathogenic protozoa. Therefore, new solutions are being sought as alternatives to currently used agents. There are many new ideas and solutions, especially compounds of natural origin, including essential oils. In the present study, the antiprotozoal activity of a mixture of essential oils (eucalyptus, lavender, cedar and tea tree), organic acids (acetic acid, propionic acid and lactic acid) and metal ions (Cu, Zn, Mn) were tested. As a model, protozoans were selected: Euglena gracilis, Gregarina blattarum, Amoeba proteus, Paramecium caudatum, Pentatrichomonas hominis. The tested concentrations of mixtures were in the range of 0.001–1.5%. The analyses show unexpected, very strong protozoicidal activity of combinations, presenting the synergy of compounds via determination of LD50 and LD100 values. Obtained mixtures showed significantly higher activity against protozoans, compared to chloramphenicol and metronidazole. Most of the analyzed samples show high antiprotozoal activity at very low concentration, in the range of 0.001–0.009%. The most effective combinations for all analyzed protozoans were the cedar essential oil and tea tree essential oil with a mixture of acids and manganese or zinc ions. Innovative combinations of essential oils, organic acids and metal ions are characterized by very high antiprotozoal activity at low doses, which, after further investigation, can be applicable for control of protozoan pathogens.

1. Introduction

Each year, more than 15 million people die worldwide due to infectious diseases caused by various pathogens including bacteria, protozoa, viruses or fungi [1]. One of the main causes of death, besides bacterial and viral diseases, are diseases caused by protozoa such as Plasmodium spp., Cryptosporidium spp., Leishmania spp. and Trypanosoma spp. [2].
The most deadly diseases caused by protozoa undoubtedly include malaria, human African trypanosomiasis (HAT, sleeping sickness), Chagas disease, Visceral leishmaniasis (VL, kala azar), toxoplasmosis, Naegleriasis (PAM—primary amoebic meningoencephalitis), babesiosis or cryptosporidiosis [2,3,4]. The most common signs of protozoan infection include diarrhea, fever, malaise or hepatosplenomegaly [2,5].
Currently, there are three main methods of controlling protozoan parasites: prevention and containment of protozoan vectors, vaccination and antibiotic-based pharmacotherapy [2,6]. Based on the example of malaria, we know that the primary and so far most effective weapon in the fight against parasitic protozoa is prevention and elimination of vectors, which are most often mosquitoes, ticks or bedbugs. To reduce the risk of infection, many international and national guidelines recommend the use of insecticide-treated bed nets (ITNs), long-lasting insecticidal nets (LLINs), indoor residual spraying (IRS) or both methods together. Moreover, control of vector abundance also contributes significantly to reduce the spread of pathogens. The most commonly used method of controlling protozoa is the use of pharmaceuticals. Most often, these are single active substances that show antimicrobial activity. These include nifurtimox, pentamidine, quinine sulfate, fexinidazoles, benznidazoles, artemisinin derivatives and chloroquine, among others. However, most of them have been marketed for completely different purposes and medical indications. Mixed therapies combining two or more pharmacological agents, for example, nifurtimox-eflornithine (NECT), artemether-lumefantrine or quinine sulfate with doxycycline, tetracycline or clindamycin are also commonly used to optimize effects [5,7,8,9,10,11].
Mixed therapies are also a response to increasing resistance of microorganisms to available antibiotics. This is currently a significant problem that affects people all over the world. Its genesis is very complex and is influenced, among others, by high mobility and the possibility of movement all over the world, inadequate hygienic and sanitary conditions or the excessive use of antibiotics both in humans and animals [12,13]. As mentioned above, reducing pathogenic protozoa, especially those showing resistance, is through combination therapy. However, without clinical trials using similar combinations, it is very difficult to estimate their cytotoxicity and interaction in the body.
The lack of new and effective antibiotics causes the need for another alternative. This leads very often to developing an effective method to fight protozoa. The object of interest of researchers around the world are currently natural compounds extracted or obtained from plants [14,15,16]. Compounds showing antimicrobial activity include phenolic compounds, terpenes, sulfur glycosides or alkaloids [17].
Essential oils are characterized by a very high antimicrobial and antiprotozoal potential [18,19,20]. They are volatile mixtures, most of which are scented, of various substances of mainly plant origin. They are obtained via steam distillation from various fragments of plant leaves, flowers, fruits, buds, bark, seeds and even roots. They are usually stored in glandulars [21]. The growing interest in natural solutions, being an alternative to the currently used, generates new studies and reports in the literature. Papers or patents present that EOs are characterized by great antimicrobial potential. In vitro studies performed show very strong antiprotozoal activity of, e.g., tea tree oil (Melaleuca alternifolia (Maiden & Betche) Cheel) [22], lavender (Lavandula angustifolia Mill.) [23], thyme (Thymus vulgaris L.) [24], catnip (Nepeta cataria L.) [25], yarrow (Achillea millefolium L.), clove (Syzygium aromaticum L.), basil (Ocimum basilicum L.) [18], Lippia sp. [26], peppermint (Mentha piperita L.) [27] and rosemary (Rosmarinus officinalis L.) [28]. The current interest in natural alternatives to the available therapies is generating an increasing amount of scientific research. A growing number of studies are also investigating the antiprotozoal properties of individual components of essential oils, such as monoterpenoids and sesquiterpenoids as well as their alcohol, ester or ketone derivatives [29].
Organic acids are commonly known compounds used in food, cosmetic, feed and pharmaceutical markets as acidifiers, stabilizers, acidity regulators or preservatives. The last feature has been used widely through the ages for food prevention. That property is mainly based on the lowering of the pH, which results in the inhibition of microbials. Organic acids show very good results in broilers and fish production, by their antibacterial and antiprotozoal properties [30,31,32,33].
The combination of metals, e.g., iron, cobalt, nickel, gallium, copper, gold or silver with drugs are well known and very effective. Complex of Ru(II) chloroquine was one of the first tested antiprotozoal drugs combined with metal ions and showed a much better result than chloroquine itself. Other examples tested and evaluated for their antiprotozoal properties can be auranofin, triethylphosphine gold(I) chloride, cisplatin, 2-mercaptopyridine N-oxide complexes with Pt(II), Au(I) and Pd(II), or one of the most efficient for organometallic compounds, ferroquine [34,35,36]. Moreover, not only do the combining synthetic drugs and metals have great potential. Natural compounds such as essential oils, alkaloids and phenols in combination with metal ions are also investigated by researchers [37].
The mode of action of metal ions, mostly, is to impair the proper function of the cell membrane. They may be incorporated with the cell membrane, modulate ion channels, disrupt proton transfer or electrostatically interact with charges on the membrane surface. Metal ions can also affect various cell processes within cytoplasm such as inhibition of enzymes and proteins, catalyze the n of oxygen and hydroperoxide radicals and interrupt nutrient uptake [37,38,39].
The aim of this study was to investigate antiprotozoal properties of an innovative mixture of essential oils (eucalyptus, lavender, cedar and tea tree), organic acids (acetic, propionic, lactic) and metal ions (Cu, Zn and Mn). Previous research and scientific papers showed antiprotozoal properties of all components, but there were no scientific data about the proposed combinations.

2. Results

2.1. Antiprotozoal Activity

In the study, antiprotozoal properties were analyzed for single components of the mixtures: 48 combinations (4 essential oils with 3 metals and 3 organic acids and their mixtures). All obtained combinations are presented in Table 1. Chloramphenicol and metronidazole were used as standard substances. The obtained results are presented in Table 2, Table 3, Table 4, Table 5, Table 6, Table 7, Table 8 and Table 9. They are characterized by variable efficiency depending on the combination used and the protozoan species. The combinations containing an essential oil, a single acid and one of the selected metals showed much stronger antiprotozoal properties than the single components, and in some cases, than the antibiotics used for comparison. Among these combinations, the combination of tea tree essential oil, with propionic acid and manganese (TPMn) showed the highest potential. TPMn showed LD50, at a very low amount—0.01%. That result is much better than the reference antibiotics—chloramphenicol and metronidazole. It was also observed that the strongest activity independently of the used oil was observed for propionic acid and manganese ions.
The lowest antiprotozoal values against analyzed protozoa were obtained for innovative combinations of essential oil with the mixture of organic acids and selected metal. They showed an activity almost ten times stronger than that of analogous mixtures containing a single organic acid and an activity almost a hundred times stronger than that of single essential oils. Many of the proposed combinations showed activity against protozoa in the lowest tested concentration—0.001%. Most of the mixtures were very effective against Euglena gracilis. This protozoa was the most vulnerable form of all tested organisms. The concentration 0.001% was equal LD50 for 4 combinations, tea tree essential oil, mixture of acids and copper (TMCu); tea tree essential oil, mixture of acids and manganese (TMMn); cedar essential oil, mixture of acids and copper (CMCu); lavender essential oil, mixture of acids and manganese (LMMn). The highest concentration for the essential oil, mixture of acids and metal ions was obtained for the tea tree essential oil, mixture of acids and manganese (TMMn)—0.009%. Nevertheless, all the combinations with manganese ions showed the best results for all protozoans. However, it should be noted that the worst result for the combination of essential oil, mixture of acids and metal, is more than 10 times better than for the reference substance, which in this case is metronidazole. The values obtained for the remaining combinations were characterized by significantly lower effective doses than the reference substances, chloramphenicol or metronidazole. The mixtures with highest potential and lowest LD50 and LD100 values can be found in Table 10. Comparison between the most effective compositions, analysis of variance (ANOVA) using Tukey’s test, are presented in the Supplementary Materials.

2.2. GC-MS Analysis of the Compositions

The chromatograms (presented in Supplementary Materials Figures S1–S4) show the chemical composition of the four essential oils used. Presented in Tables S1–S4 proves the typical mixtures for these essential oils’ composition. Predominated compounds for lavender EOs are linalyl acetate, linalool, 1-terpinen-4-ol and eucalyptol. In case of eucalyptus oil, 80.7% of the sum of the investigated compounds is an 1,8-cineol (eucalyptol) together with p-cymene 9.8%. Tea tree oil was rich in terpineols (mainly 1-terpinen-4-ol ~40%) with corresponding terpinenes (respectively γ–15.4% and α–9%). Finally, cedar oil was himachalene chemotype (β-isomer, 27.3% and α, with 9.1% content) together with sesquiterpenoic atlantone (isomer Z, 12.3% and trans-α 9.6%).
Detailed composition of investigated EOs are presented in Tables S1–S4.

3. Discussion

The results of the in vitro studies presented below confirm the antiprotozoal properties of blends which contained in their composition essential oils (eucalyptus, cedar, lavender or tea tree) with organic acids (acetic, propionic, lactic) and metal ions (Cu, Zn, Mn).
The combination containing essential oils, organic acids and metal ions was a concept that occurred after several years of research on natural alternatives for antibiotics. Moreover, and what is very important, all of the used components are allowed to be used in food and feed. The idea corresponds strongly with the scientific results obtained by other researchers. Components used in this study were chosen by their antiprotozoal activity and different polarity [20,40,41,42].
To the best of our knowledge, presented in this paper, combinations of EOs, acids and metal ions were tested for the first time. The object of investigations that have been conducted, are usually combinations of two or more essential oils [43], metals [38,42], antibiotics [44,45], organic acids [46], active compounds occurring in essential oil [22], essential oils with other compounds of natural origin [47] or other compounds of plant origin e.g., alkaloids [48,49,50], triterpene saponins [51] or chalcones and flavonoids [41]. The proposed combination is characterized by innovation and, most importantly, high efficiency.
Eucalyptus oil is very well known and used worldwide. Its properties have been widely described in the literature, with particular emphasis on antibacterial and anti-inflammatory properties [52,53]. However, very little information can be found on its antiprotozoal activity. These properties were proved in the following study. Eucalyptus oil showed the same properties as the other tested combinations. It does not change the fact that its effectiveness in combination with acids and metal ions was very high at low concentrations.
Another essential oil analyzed was tea tree essential oil. For years, it has not only been the subject of research, but also an ingredient in many antifungal products [54,55]. It is also undoubtedly effective against Trichomonas vaginalis [56]. A human trial showed that a dose of 0.4% tea tree essential oil was as effective as metronidazole treatment [22]. Similar results were obtained in the following work. However, another study showed a 100% antiprotozoal efficacy of tea tree oil at 455 µL/L [57]. Similar results were obtained in the following work. Baldissera et al. showed a much higher effective concentration, 1–2%, in their study [58]. Other tests also showed its high antiprotozoal efficacy, but also high selectivity of the main component of tea tree oil—terpinen-4-ol [59]. The composition containing tea tree oil, together with a mixture of organic acids and metal ions, had the best antiprotozoal properties among the combinations tested. It exhibited a mostly lethal effect, against 50% of the population, at concentrations in the range of 0.001–0.004%.
Cedar essential oil shows very strong antibacterial, antiviral, insecticidal and antiprotozoal properties [60,61,62,63]. Studies have shown that in its pure form, it has efficacy levels of LD50 = 0.04–1% and LD100 = 0.06–0.25% against analyzed protozoa. Obtained concentrations were very low. Unlike the C. deodara species, Cedrus libani did not show antiprotozoal properties against Leishmania major [64]. Nisha et al. showed similar activity and effective concentration against the adult form of Setaria digitata [65]. In their study, Kar et al. showed a significant enhancement of the effect of cedrol, one of the major components of cedar essential oil, as a cedrol-loaded nano-structured lipid carrier [66]. In our studies, the combination of cedar oil with a mixture of acids and metal ions showed very good antiprotozoal properties in the range of 0.001–0.008% against the analyzed protozoa. Compared to the values obtained for cedar essential oil, it is 40 times and more than 30 times more potent, LD50 and LD100, respectively.
Many studies present the high activity effects of lavender oil against microorganisms [67]. However, there are few reports in the literature on its antiprotozoal activity. The results presented in this paper allow us to conclude that lavender oil, especially in the proposed combinations, show very good antiprotozoal properties. The values for pure lavender oil were promising, while the combinations performed only confirmed this. All analyzed variants of lavender essential oil, mixture of acids and Cu, Mn, Zn ions (LMCu, LMMn and LMZn) showed strong protozoicidal activity at the level of 0.001–0.008%.
This article shows the very good antiprotozoal properties of the innovative combinations. The results obtained in this research are often even a hundred times stronger than those of standard antibiotics.
It is necessary to conduct further tests with using the analyzed mixtures. The obligatory element is undoubtedly the analysis of the toxicity of the combination and its direct influence on organs, as well as accumulation in tissues. However, the mixtures obtained have a very high potential and can be used not only in medicine and pharmacy, but also in the prophylaxis of diseases caused by protozoa, both in humans and animals.

4. Materials and Methods

4.1. Maintenance of Parasite Cultures and Evaluation of Antiprotozoal Activity

Five organisms representing the taxonomic groups to which the pathogenic protozoa belong were selected for in vitro studies of the antiprotozoal activity of the mixtures:
  • Amoeba proteus—Chaos diffluens—a protozoan of the order Euamoebida, belonging to the phylum Amoebozoa, living in water.
  • Paramecium caudatum—a paramecium representing aquatic ciliates.
  • Gregarina blattarum—gregarines were isolated from cockroaches, representing the type Apicomplexa, living in the digestive tracts or body cavities of invertebrates.
  • Euglena gracilis—a protozoan living in water, representing the flagellates—Mastigophora, family Euglenaceae.
  • Pentatrichomonas hominis—a protozoan that lives in the human colon, representing the Trichomonadidae.
The Amoeba, Paramecium and Euglena studied in this work were isolated from the freshwater river in Krosno (river Bado, 49°39’59.8’ N 21°46’28.1’ E, Krosno, Subcarpathian Voivodeship, Poland).
Amoeba proteus was cultivated in the Prescott medium and was fed with ciliates, for example, Tetrahymena and Chilomonas [68,69]. Paramecium was cultivated in hay infusion [70,71,72]. Euglena was cultivated in solution according to Wu [73]. Pentatrichomonas hominis was isolated from stool samples and kept in Pahm solution according to Chomicz et al. [74]
The gregarines were isolated from cockroaches and treated with the mixtures at different concentrations after being placed on a watch glass in Ringer’s solution. Each sample included ten individuals. The isolation of gregarine from cockroaches was carried out according to the method of isolation of gregarines from beetles proposed by J. Moraczewski [75].
Amoeba, Paramecium and Euglena were observed microscopically on a watch glass with viscose wool fibers (to facilitate observation) in a drop of culture water, from which they originated. Different concentrations of the combinations were introduced into the test samples, establishing an LD50 dose (50% mortality) and an LD100 dose (100% mortality). For determining LD50, the Reed–Muench method was used. In all cases, four-fold replicates of the test were used along with a blank test. The lethal concentration of the substance LD50 and LD100 within 3 and 5 min was determined.
Identification of individual protozoa was made on the basis of their descriptions and drawings after W. A. Dogiel [76] and J. Hempel-Zawitkowska [35,77].
The obtained mixtures of phytoncides with metals and single phytoncides were dissolved in an aqueous solution of polysorbate 80 (0.05%) before being applied to a watch glass. No biocidal effect of polysorbate 80 was observed at the above concentrations. Chloramphenicol and metronidazole were used as standard substances to control protozoa. Concentration of the antibiotics were 5 mg/mL and the dilutions were prepared from the stock to reach LD50 and LD100.

4.2. Essential Oils

Essential oils were ordered from two companies. Eucalyptus and tea tree were purchased from Food Base Kft. (Gödöllő, Hungary), cedar essential oil from Synthite Industries Pvt., Ltd. (Kolenchery, Kerala, India) and lavender essential oil from De Monchy Aromatics Ltd. (Poole, Dorset, UK)

4.3. Chemicals and Reagents

Organic acids (acetic acid 99%, propionic acid 99.5% and lactic acid 85%) and other chemical reagents purchased from Sigma-Aldrich (St. Louis, MO, USA) comply with FCC and FG standards. The purity and percentage composition, according to the supplier’s specification, was minimum ≥95%.

4.4. Phytoncides Mixture Preparation

Essential oils (100 mL) were added in the same amount to organic acids (100 mL) or mixture of acids (ratio 1:1:1) and 5 g of copper (II) carbonate hydroxide (2.87 g of ions Cu2+) or 5 g zinc carbonate (2.61 g of ions Zn2+) or 5 g manganese (II) chloride (2.18 g of ions Mn2+). The entire mixture was heated until the color changed. The mixture was then allowed to cool to obtain a clear solution (one, two or three phases). After this time, the mixture was filtered through a paper filter. The combination was diluted: 1.5% to 0.001%; after that, the protozoa were placed in each dilution.

4.5. GC-MS Analysis

The profile of the essential oils investigated was assessed using the GC-MS technique according to the protocol [78]. Identification of all volatile constituents was based on comparison of experimentally obtained compound’s mass spectra with mass spectra available in the NIST20 database. Additionally, the retention indices (RI) obtained experimentally, calculated using macro [79], were compared with the RI available in the NIST20 database and the data from the literature [80]. Shimadzu software GCMS Postrun Analysis (Shimadzu Company, Kyoto, Japan) and ACD/Spectrus Processor (Advanced Chemistry Development, Inc., Toronto, ON, Canada) were used to process the data. The quantification of identified constituents was performed by calculation based on the amount of added internal standard and expressed as a percentage of integrated peaks’ area. Analysis was performed using the Shimadzu 2020 apparatus (Varian, Walnut Creek, CA, USA) equipped with a Zebron ZB-5 MSI (30 m × 0.25 mm × 0.25 μm) column (Phenomenex, Torrance, CA, USA). The temperature of the GC oven was programmed from 50 °C to 250 °C at a rate of 3.0 °C and kept for 3 min. Scanning was performed from 35 to 550 m/z in electronic impact (EI) at 70 eV and ion source temperature 250 °C. Samples were injected at split ratio 1:10 and gas helium was used as the carrier gas at a flow rate of 1.0 mL/min.

4.6. Statistical Analysis

The data, from LD50 and LD100 evaluation, were subjected to the analysis of variance (ANOVA) using Tukey’s test (p < 0.05) using the STATISTICA 13.3 software for Windows (StatSoft, Krakow, Poland).

5. Conclusions

In the presented work, a hitherto unused combination of three types of compounds: essential oils, organic acids and metal ions, was used. It has been proved that the proposed combinations show very strong antiprotozoal activity. Studies conducted so far allow to conclude the synergistic effect of these combinations and obtain protozoicidal results much better than standard antibiotics—chloramphenicol or metronidazole. Very high effectiveness against all of the analyzed protozoans was found in the combinations of tea tree, cedar and lavender essential oils, mixture of acids and all of the ions. The LD50 and LD100 values were in the range 0.001–0.009%. The highest antiprotozoal properties were obtained in the combination with cedar and tea tree essential oils, mixture of acids and manganese or zinc ions. The proposed combinations may find application in eradication of protozoan diseases both in humans and animals. However, further steps should be taken to analyze the antiprotozoal effect on model protozoa such as Cryptosporidium spp., Leishmania spp. and Trypanosoma spp. as well as toxicological studies of the effective concentrations.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics11070913/s1, Figure S1: GC-MS chromatogram of tea tree essential oil, Figure S2: GC-MS chromatogram of cedar essential oil, Figure S3: GC-MS chromatogram of eucalyptus essential oil, Figure S4: GC-MS chromatogram of lavender oil, Table S1: Composition of tea tree essential oil, Table S2: Composition of cedar essential oil, Table S3: Composition of eucalyptus essential oi, Table S4: Composition of lavender essential oil.

Author Contributions

Conceptualization, H.I., H.R. and A.S.; methodology, H.I., H.R. and A.S.; investigation, H.I., H.R., A.S. and J.Ł.; data curation, H.I., H.R. and A.S.; validation H.I., H.R. and A.S.; writing—original draft preparation, H.I., H.R. and A.S.; writing—review and editing, H.I., J.Ł. and A.S.; visualization, H.I. and A.S.; supervision, H.R. and A.S. All authors have read and agreed to the published version of the manuscript.

Funding

This study is supported by Ministry of Education and Science (Implementation Doctorates Project 2nd edition—Doktorat Wdrożeniowy).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in the Supplementary Materials.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Kalt, M.-M.; Schuehly, W.; Saf, R.; Ochensberger, S.; Solnier, J.; Bucar, F.; Kaiser, M.; Presser, A. Palladium-catalysed synthesis of arylnaphthoquinones as antiprotozoal and antimycobacterial agents. Eur. J. Med. Chem. 2020, 207, 112837. [Google Scholar] [CrossRef]
  2. Korpe, P.S.; Ravdin, J.I.; Petri, W.A. 271—Introduction to Protozoal Diseases. In Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th ed.; Bennett, J.E., Dolin, R., Blaser, M.J., Eds.; W.B. Saunders: Philadelphia, PA, USA, 2020; pp. 3270–3272. [Google Scholar] [CrossRef]
  3. Mitra, A.K.; Mawson, A.R. Neglected Tropical Diseases: Epidemiology and Global Burden. Trop. Med. Infect. Dis. 2017, 2, 36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Benítez, J.; Guggeri, L.; Tomaz, I.; Arrambide, G.; Navarro, M.; Costa Pessoa, J.; Garat, B.; Gambino, D. Design of vanadium mixed-ligand complexes as potential anti-protozoa agents. J. Inorg. Biochem. 2009, 103, 609–616. [Google Scholar] [CrossRef] [PubMed]
  5. Fairhurst, R.; Wellems, T. Plasmodium species (Malaria). Princ. Pract. Infect. Dis. 2014, 2, 3437–3462. [Google Scholar] [CrossRef]
  6. Andrews, K.T.; Fisher, G.; Skinner-Adams, T.S. Drug repurposing and human parasitic protozoan diseases. Int. J. Parasitol. Drugs Drug Resist. 2014, 4, 95–111. [Google Scholar] [CrossRef] [Green Version]
  7. CDC. How Can Malaria Cases and Deaths Be Reduced? Availabe online: https://www.cdc.gov/malaria/malaria_worldwide/reduction/index.html (accessed on 3 May 2022).
  8. WHO. Guideline WHO Guidelines for Malaria, 16 February 2021; World Health Organization: Geneva, Switzerland, 2021. [Google Scholar]
  9. WHO. WHO Interim Guidelines for the Treatment of Gambiense Human African Trypanosomiasis; World Health Organization: Geneva, Switzerland, 2019. [Google Scholar]
  10. PAHO. Guidelines for the Diagnosis and Treatment of Chagas Disease; Pan American Health Organization: Washington, DC, USA, 2019. [Google Scholar]
  11. Lindner, A.K.; Lejon, V.; Chappuis, F.; Seixas, J.; Kazumba, L.; Barrett, M.P.; Mwamba, E.; Erphas, O.; Akl, E.A.; Villanueva, G.; et al. New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: Substantial changes for clinical practice. Lancet. Infect. Dis. 2020, 20, e38–e46. [Google Scholar] [CrossRef]
  12. Aslam, B.; Wang, W.; Arshad, M.I.; Khurshid, M.; Muzammil, S.; Rasool, M.H.; Nisar, M.A.; Alvi, R.F.; Aslam, M.A.; Qamar, M.U.; et al. Antibiotic resistance: A rundown of a global crisis. Infect Drug Resist 2018, 11, 1645–1658. [Google Scholar] [CrossRef] [Green Version]
  13. Rolta, R.; Sharma, A.; Sourirajan, A.; Mallikarjunan, P.K.; Dev, K. Combination between antibacterial and antifungal antibiotics with phytocompounds of Artemisia annua L: A strategy to control drug resistance pathogens. J. Ethnopharmacol. 2021, 266, 113420. [Google Scholar] [CrossRef]
  14. Abou Baker, D.H.; Al-Moghazy, M.; ElSayed, A.A.A. The in vitro cytotoxicity, antioxidant and antibacterial potential of Satureja hortensis L. essential oil cultivated in Egypt. Bioorganic Chem. 2020, 95, 103559. [Google Scholar] [CrossRef]
  15. Gavanji, S.; Zaker, S.R.; Nejad, Z.G.; Bakhtari, A.; Bidabadi, E.S.; Larki, B. Comparative efficacy of herbal essences with amphotricin B and ketoconazole on Candida albicans in the in vitro condition. Integr. Med. Res. 2015, 4, 112–118. [Google Scholar] [CrossRef] [Green Version]
  16. Derda, M.; Hadaś, E. The use of phytotherapy in diseases caused by parasitic protozoa. Acta Parasitol. 2014, 60, 1–8. [Google Scholar] [CrossRef] [PubMed]
  17. Van Zyl, R.L.; Seatlholo, S.T.; Viljoen, A.M. Pharmacological interactions of essential oil constituents on the in vitro growth of Plasmodium falciparum. S. Afr. J. Bot. 2010, 76, 662–667. [Google Scholar] [CrossRef] [Green Version]
  18. Santoro, G.F.; Cardoso, M.G.; Guimarães, L.G.L.; Mendonça, L.Z.; Soares, M.J. Trypanosoma cruzi: Activity of essential oils from Achillea millefolium L., Syzygium aromaticum L. and Ocimum basilicum L. on epimastigotes and trypomastigotes. Exp. Parasitol. 2007, 116, 283–290. [Google Scholar] [CrossRef] [PubMed]
  19. Rodrigues Goulart, H.; Kimura Emília, A.; Peres Valnice, J.; Couto Alicia, S.; Aquino Duarte Fulgencio, A.; Katzin Alejandro, M. Terpenes Arrest Parasite Development and Inhibit Biosynthesis of Isoprenoids in Plasmodium falciparum. Antimicrob. Agents Chemother. 2004, 48, 2502–2509. [Google Scholar] [CrossRef] [Green Version]
  20. Monzote, L.; Alarcón, O.; Setzer, W. Antiprotozoal Activity of Essential Oils. Agric. Conspec. Sci. 2012, 77, 167–175. [Google Scholar]
  21. Carson, C.F.; Hammer, K.A. Chemistry and Bioactivity of Essential Oils. In Lipids and Essential Oils as Antimicrobial Agents; Thormar, H., Ed.; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2011; pp. 203–238. [Google Scholar] [CrossRef]
  22. Lam, N.S.; Long, X.; Su, X.-Z.; Lu, F. Melaleuca alternifolia (tea tree) oil and its monoterpene constituents in treating protozoan and helminthic infections. Biomed. Pharmacother. 2020, 130, 110624. [Google Scholar] [CrossRef]
  23. Moon, T.; Wilkinson, J.; Cavanagh, H. Antiparasitic activity of two Lavandula essential oils against Giardia duodenalis, Trichomonas vaginalis and Hexamita inflata. Parasitol. Res. 2006, 99, 722–728. [Google Scholar] [CrossRef]
  24. Behnia, M.; Haghighi, A.; Komeylizadeh, H.; Tabaei, S.J.; Abadi, A. Inhibitory effects of Iranian Thymus vulgaris extracts on in vitro growth of Entamoeba histolytica. Korean J. Parasitol. 2008, 46, 153–156. [Google Scholar] [CrossRef]
  25. Saeidnia, S.; Gohari, A.; Hadjiakhoondi, A. Trypanocidal oil of the young leaves of Nepeta cataria L., obtained by solvent extraction. J. Med. Plants 2008, 7, 54–57. [Google Scholar]
  26. De Melo, A.R.B.; Maciel Higino, T.M.; da Rocha Oliveira, A.D.P.; Fontes, A.; da Silva, D.C.N.; de Castro, M.C.A.B.; Dantas Lopes, J.A.; de Figueiredo, R.C.B.Q. Lippia sidoides and Lippia origanoides essential oils affect the viability, motility and ultrastructure of Trypanosoma cruzi. Micron 2020, 129, 102781. [Google Scholar] [CrossRef]
  27. Ferreira, L.C.; Cruz, M.G.d.; Lima, T.B.C.; Serra, B.N.V.; Chaves, F.C.M.; Chagas, E.C.; Ventura, A.S.; Jerônimo, G.T. Antiparasitic activity of Mentha piperita (Lamiaceae) essential oil against Piscinoodinium pillulare and its physiological effects on Colossoma macropomum (Cuvier, 1818). Aquaculture 2019, 512, 734343. [Google Scholar] [CrossRef]
  28. Anacarso, I.; Sabia, C.; de Niederhäusern, S.; Iseppi, R.; Condò, C.; Bondi, M.; Messi, P. In vitro evaluation of the amoebicidal activity of rosemary (Rosmarinus officinalis L.) and cloves (Syzygium aromaticum L. Merr. & Perry) essential oils against Acanthamoeba polyphaga trophozoites. Nat. Prod. Res. 2019, 33, 606–611. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. van Zyl, R.L.; Seatlholo, S.T.; van Vuuren, S.F.; Viljoen, A.M. The Biological Activities of 20 Nature Identical Essential Oil Constituents. J. Essent. Oil Res. 2006, 18, 129–133. [Google Scholar] [CrossRef]
  30. Hauser, C.; Thielmann, J.; Muranyi, P. Chapter 46—Organic Acids: Usage and Potential in Antimicrobial Packaging. In Antimicrobial Food Packaging; Barros-Velázquez, J., Ed.; Academic Press: San Diego, CA, USA, 2016; pp. 563–580. [Google Scholar] [CrossRef]
  31. Meira-Filho, M.R.C.; Ramirez, J.R.B.; Vianna, R.T.; Júnior, J.P. Efficacy of glacial acetic acid in the control of Trichodina sp. and Apiosoma sp. associated with Mugil liza. Aquaculture 2017, 479, 7–12. [Google Scholar] [CrossRef]
  32. Surve, A.N.; Sherikar, A.T.; Bhilegaonkar, K.N.; Karkare, U.D. Preservative effect of combinations of acetic acid with lactic or propionic acid on buffalo meat stored at refrigeration temperature. Meat Sci. 1991, 29, 309–322. [Google Scholar] [CrossRef]
  33. Aljumaah, M.R.; Alkhulaifi, M.M.; Abudabos, A.M.; Alabdullatifb, A.; El-Mubarak, A.H.; Al Suliman, A.R.; Stanley, D. Organic acid blend supplementation increases butyrate and acetate production in Salmonella enterica serovar Typhimurium challenged broilers. PLoS ONE 2020, 15, e0232831. [Google Scholar] [CrossRef]
  34. Marcelino, P.R.F.; Moreira, M.B.; Lacerda, T.M.; da Silva, S.S. Metal-Based Drugs for Treatment of Malaria. Biomed. Appl. Met. 2017, 167–193. [Google Scholar] [CrossRef]
  35. Navarro, M.; Gabbiani, C.; Messori, L.; Gambino, D. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: Recent achievements and perspectives. Drug Discov. Today 2010, 15, 1070–1078. [Google Scholar] [CrossRef]
  36. Wani, W.A.; Jameel, E.; Baig, U.; Mumtazuddin, S.; Hun, L.T. Ferroquine and its derivatives: New generation of antimalarial agents. Eur. J. Med. Chem. 2015, 101, 534–551. [Google Scholar] [CrossRef]
  37. Low, W.-L.; Kenward, K.; Britland, S.T.; Amin, M.C.; Martin, C. Essential oils and metal ions as alternative antimicrobial agents: A focus on tea tree oil and silver. Int. Wound J. 2017, 14, 369–384. [Google Scholar] [CrossRef]
  38. Low, W.L.; Martin, C.; Hill, D.J.; Kenward, M.A. Antimicrobial efficacy of silver ions in combination with tea tree oil against Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans. Int. J. Antimicrob. Agents 2011, 37, 162–165. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Kiss, T.; Osipenko, O. Metal ion-induced permeability changes in cell membranes: A minireview. Cell. Mol. Neurobiol. 1994, 14, 781–789. [Google Scholar] [CrossRef] [PubMed]
  40. Ed-Dra, A.; Filali, F.R.; Lo Presti, V.; Zekkori, B.; Nalbone, L.; Bouymajane, A.; Trabelsi, N.; Lamberta, F.; Bentayeb, A.; Giuffrida, A.; et al. Chemical composition, antioxidant capacity and antibacterial action of five Moroccan essential oils against Listeria monocytogenes and different serotypes of Salmonella enterica. Microb. Pathog. 2020, 149, 104510. [Google Scholar] [CrossRef]
  41. Sen, R.; Chatterjee, M. Plant derived therapeutics for the treatment of Leishmaniasis. Phytomedicine 2011, 18, 1056–1069. [Google Scholar] [CrossRef] [PubMed]
  42. Ahmad, A.; Viljoen, A. The in vitro antimicrobial activity of Cymbopogon essential oil (lemon grass) and its interaction with silver ions. Phytomedicine 2015, 22, 657–665. [Google Scholar] [CrossRef]
  43. Zenner, L.; Callait, M.P.; Granier, C.; Chauve, C. In vitro effect of essential oils from Cinnamomum aromaticum, Citrus limon and Allium sativum on two intestinal flagellates of poultry, Tetratrichomonas gallinarum and Histomonas meleagridis. Parasite 2003, 10, 153–157. [Google Scholar] [CrossRef] [Green Version]
  44. Jugreet, B.S.; Mahomoodally, M.F. Reprint of: Essential oils from 9 exotic and endemic medicinal plants from Mauritius shows in vitro antibacterial and antibiotic potentiating activities. S. Afr. J. Bot. 2021, 140, 478–485. [Google Scholar] [CrossRef]
  45. Mazoir, N.; Dakir, M.; Tebbaa, M.; Loughzail, M.; Benharref, A. Aromatization of (Z) and (E)-α-atlantones isolated from Cedrus atlantica essential oil followed by condensation with thiosemicarbazide: Synthesis of new thiadiazolines derivatives. Tetrahedron Lett. 2016, 57, 278–280. [Google Scholar] [CrossRef]
  46. Zhang, S.; Shen, Y.R.; Wu, S.; Xiao, Y.Q.; He, Q.; Shi, S.R. The dietary combination of essential oils and organic acids reduces Salmonella enteritidis in challenged chicks. Poult. Sci. 2019, 98, 6349–6355. [Google Scholar] [CrossRef]
  47. Katopodi, A.; Detsi, A. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers of natural products as promising systems for their bioactivity enhancement: The case of essential oils and flavonoids. Colloids Surf. A Physicochem. Eng. Asp. 2021, 630, 127529. [Google Scholar] [CrossRef]
  48. Sahu, A.; Agrawal, R.K.; Pandey, R. Synthesis and systemic toxicity assessment of quinine-triazole scaffold with antiprotozoal potency. Bioorganic Chem. 2019, 88, 102939. [Google Scholar] [CrossRef]
  49. Nair, J.J.; van Staden, J. Antiprotozoal alkaloid principles of the plant family Amaryllidaceae. Bioorganic Med. Chem. Lett. 2019, 29, 126642. [Google Scholar] [CrossRef] [PubMed]
  50. Cimanga Kanyanga, R.; Kikweta Munduku, C.; Nsaka Lumpu, S.; Tshodi Ehata, M.; Makila Bool-Miting, F.; Kambu Kabangu, O.; Mbamu Maya, B.; Cos, P.; Maes, L.; Vlietinck, A.J.; et al. Isolation and structure elucidation of two antiprotozoal bisbenzylisoquinoline alkaloids from Triclisia gilletii stem bark. Phytochem. Lett. 2018, 28, 19–23. [Google Scholar] [CrossRef]
  51. Mostafa, A.E.; El-Hela, A.A.; Mohammad, A.-E.I.; Cutler, S.J.; Ross, S.A. New triterpenoidal saponins from Koelreuteria paniculata. Phytochem. Lett. 2016, 17, 213–218. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Bello, M.; Jiddah-kazeem, B.; Fatoki, T.H.; Ibukun, E.O.; Akinmoladun, A.C. Antioxidant property of Eucalyptus globulus Labill. Extracts and inhibitory activities on carbohydrate metabolizing enzymes related to type-2 diabetes. Biocatal. Agric. Biotechnol. 2021, 36, 102111. [Google Scholar] [CrossRef]
  53. Aleksic Sabo, V.; Knezevic, P. Antimicrobial activity of Eucalyptus camaldulensis Dehn. plant extracts and essential oils: A review. Ind. Crop. Prod. 2019, 132, 413–429. [Google Scholar] [CrossRef] [PubMed]
  54. Zhang, J.; Wu, H.; Jiang, D.; Yang, Y.; Tang, W.; Xu, K. The antifungal activity of essential oil from Melaleuca leucadendra (L.) L. grown in China and its synergistic effects with conventional antibiotics against Candida. Nat. Prod. Res. 2019, 33, 2545–2548. [Google Scholar] [CrossRef]
  55. Murray, M.T. 91—Melaleuca alternifolia (Tea Tree). In Textbook of Natural Medicine, 5th ed.; Pizzorno, J.E., Murray, M.T., Eds.; Churchill Livingstone: St. Louis, MO, USA, 2020; pp. 693–696. [Google Scholar] [CrossRef]
  56. Carson, C.F.; Hammer, K.A.; Riley, T.V. Melaleuca alternifolia (Tea Tree) oil: A review of antimicrobial and other medicinal properties. Clin. Microbiol. Rev. 2006, 19, 50–62. [Google Scholar] [CrossRef] [Green Version]
  57. Valladão, G.M.R.; Gallani, S.U.; Ikefuti, C.V.; da Cruz, C.; Levy-Pereira, N.; Rodrigues, M.V.N.; Pilarski, F. Essential oils to control ichthyophthiriasis in pacu, Piaractus mesopotamicus (Holmberg): Special emphasis on treatment with Melaleuca alternifolia. J. Fish Dis. 2016, 39, 1143–1152. [Google Scholar] [CrossRef]
  58. Baldissera, M.D.; Da Silva, A.S.; Oliveira, C.B.; Santos, R.C.V.; Vaucher, R.A.; Raffin, R.P.; Gomes, P.; Dambros, M.G.C.; Miletti, L.C.; Boligon, A.A.; et al. Trypanocidal action of tea tree oil (Melaleuca alternifolia) against Trypanosoma evansi in vitro and in vivo used mice as experimental model. Exp. Parasitol. 2014, 141, 21–27. [Google Scholar] [CrossRef]
  59. Mikus, J.; Harkenthal, M.; Steverding, D.; Reichling, J. In vitro effect of essential oils and isolated mono- and sesquiterpenes on Leishmania major and Trypanosoma brucei. Planta Med. 2000, 66, 366–368. [Google Scholar] [CrossRef] [PubMed]
  60. Ainane, A.; Khammour, F.; Charaf, S.; Elabboubi, M.; Elkouali, M.; Talbi, M.; Benhima, R.; Cherroud, S.; Ainane, T. Chemical composition and insecticidal activity of five essential oils: Cedrus atlantica, Citrus limonum, Rosmarinus officinalis, Syzygium aromaticum and Eucalyptus globules. Mater. Today Proc. 2019, 13, 474–485. [Google Scholar] [CrossRef]
  61. Chaudhary, A.K.; Ahmad, S.; Mazumder, A. Cedrus deodara (Roxb.) Loud.: A Review on its Ethnobotany, Phytochemical and Pharmacological Profile. Pharmacogn. J. 2011, 3, 12–17. [Google Scholar] [CrossRef] [Green Version]
  62. Saab, A.M.; Gambari, R.; Sacchetti, G.; Guerrini, A.; Lampronti, I.; Tacchini, M.; El Samrani, A.; Medawar, S.; Makhlouf, H.; Tannoury, M.; et al. Phytochemical and pharmacological properties of essential oils from Cedrus species. Nat. Prod. Res. 2018, 32, 1415–1427. [Google Scholar] [CrossRef] [PubMed]
  63. Bisht, A.; Jain, S.; Misra, A.; Dwivedi, J.; Paliwal, S.; Sharma, S. Cedrus deodara (Roxb. ex D.Don) G.Don: A review of traditional use, phytochemical composition and pharmacology. J. Ethnopharmacol. 2021, 279, 114361. [Google Scholar] [CrossRef]
  64. Motazedian, M.H.; Mikaeili, F.; Mohebali, M.; Miri, R.; Habibi, P.; Kamarloie, S. The antileishmanial effects of Lowsonia inermis and Cedrus libani on Leishmania major promastigotes: An in vitro study. J. Parasit. Dis. 2017, 41, 375–379. [Google Scholar] [CrossRef]
  65. Nisha, M.; Kalyanasundaram, M.; Paily, K.P.; Abidha; Vanamail, P.; Balaraman, K. In vitro screening of medicinal plant extracts for macrofilaricidal activity. Parasitol. Res. 2007, 100, 575–579. [Google Scholar] [CrossRef] [PubMed]
  66. Kar, N.; Chakraborty, S.; De, A.K.; Ghosh, S.; Bera, T. Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes. Eur. J. Pharm. Sci. 2017, 104, 196–211. [Google Scholar] [CrossRef]
  67. Kazemi, M.; Mohammadifar, M.; Aghadavoud, E.; Vakili, Z.; Aarabi, M.H.; Talaei, S.A. Deep skin wound healing potential of lavender essential oil and licorice extract in a nanoemulsion form: Biochemical, histopathological and gene expression evidences. J. Tissue Viability 2020, 29, 116–124. [Google Scholar] [CrossRef]
  68. Yudin, A.L. Amoeba and Other Protozoa. In Animal Species for Developmental Studies: Volume 1 Invertebrates; Dettlaff, T.A., Vassetzky, S.G., Eds.; Springer: Boston, MA, USA, 1990; pp. 1–11. [Google Scholar] [CrossRef]
  69. Demin, S.Y.; Berdieva, M.A.; Podlipaeva, Y.I.; Goodkov, A.V. Karyotypic instability of endoprophase and mitotic cells of Amoeba sp. strain Cont from the “proteus-type” group (Amoebozoa, Euamoebida, Amoebidae). Eur. J. Protistol. 2020, 74, 125691. [Google Scholar] [CrossRef]
  70. Pawlaczyk-Szpilowa, M. Ćwiczenia z Mikrobiologii Wody i Ścieków; PWN: Warszawa, Poland, 1980. [Google Scholar]
  71. Sonneborn, T.M. Chapter 12 Methods in Paramecium Research. In Methods in Cell Biology; Prescott, D.M., Ed.; Academic Press: New York, NY, USA, 1970; Volume 4, pp. 241–339. [Google Scholar]
  72. Feng, J.; Zhu, H.; Lukeš, J.; Korabečná, M.; Fohlerová, Z.; Mei, T.; Chang, H.; Neužil, P. Nanowatt simple microcalorimetry for dynamically monitoring the defense mechanism of Paramecium caudatum. Sens. Actuators A Phys. 2021, 323, 112643. [Google Scholar] [CrossRef]
  73. Wu, M.; Qin, H.; Deng, J.; Liu, Y.; Lei, A.; Zhu, H.; Hu, Z.; Wang, J. A new pilot-scale fermentation mode enhances Euglena gracilis biomass and paramylon (β-1,3-glucan) production. J. Clean. Prod. 2021, 321, 128996. [Google Scholar] [CrossRef]
  74. Chomicz, L.; Padzik, M.; Laudy, A.; Kozłowska, M.; Pietruczuk, A.; Piekarczyk, J.; Godineau, N.; Olędzka, G.; Kazimierczuk, Z. Anti-Pentatrichomonas hominis activity of newly synthesized benzimidazole derivatives—In vitro studies. Acta Parasitol. 2009, 54, 165–171. [Google Scholar] [CrossRef]
  75. Moraczewski, J. Ćwiczenia z zoologii bezkręgowców. Wydanie I; PWN: Warszawa, Poland, 1974; pp. 285–292. [Google Scholar]
  76. Dogiel, W.A. Zoologia Bezkręgowców. Wydanie III; Państwowe Wydawnictwo Rolnicze i Leśne: Warszawa, Poland, 1972. [Google Scholar]
  77. Hempel-Zawitkowska, J. Zoologia dla uczelni rolniczych; Wydawnictwo Naukowe PWN: Warszawa, Poland, 2006. [Google Scholar]
  78. Łyczko, J.; Pawlak, A.; Augustyński, I.; Okińczyc, P.; Szperlik, J.; Kulma, A.; Różański, H.; Obmińska-Mrukowicz, B.; Szumny, A. Chemical profiling and cytotoxic activity of 150-year old original sample of Jerusalem Balsam. Food Chem. Toxicol. 2020, 138, 111183. [Google Scholar] [CrossRef]
  79. Lucero, M.; Estell, R.; Tellez, M.; Fredrickson, E. A retention index calculator simplifies identification of plant volatile organic compounds. Phytochem. Anal. 2009, 20, 378–384. [Google Scholar] [CrossRef]
  80. Adams, R.P. Identification of Essential Oils by Ion Trap Mass Spectroscopy; Academic Press: San Diego, CA, USA, 2012. [Google Scholar]
Table 1. Combinations obtained during the research.
Table 1. Combinations obtained during the research.
Essential OilAcetic Acid (A)Propionic Acid (P)Lactic Acid (L)Mixture of Acids (M)
CuMnZnCuMnZnCuMnZnCuMnZn
Eucalyptus essential oil (Eucalyptus globulus Labill.) (E)EACuEAMnEAZnEPCuEPMnEPZnELCuELMnELZnEMCuEMMnEMZn
Tea tree essential oil (Melaleuca alternifolia (Maiden & Betche) Cheel) (T)TACuTAMnTAZnTPCuTPMnTPZnTLCuTLMnTLZnTMCuTMMnTMZn
Cedar essential oil (Cedrus sp.) (C)CACuCAMnCAZnCPCuCPMnCPZnCLCuCLMnCLZnCMCuCMMnCMZn
Lavender essential oil (Lavandula angustifolia Miller) (L)LACuLAMnLAZnLPCuLPMnLPZnLLCuLLMnLLZnLMCuLMMnLMZn
Table 2. LD50, LD100 values of eucalyptus essential oil (Eucalyptus globulus Labill.) and the components used in the study.
Table 2. LD50, LD100 values of eucalyptus essential oil (Eucalyptus globulus Labill.) and the components used in the study.
ProtozoaCH aM bAcetic AcidPropionic AcidLactic AcidMixture of Acids cManganese (II) Chloride Solution dCopper (II) Carbonate Hydroxide Solution eZinc Carbonate Solution fCatalyst Solution gEucalyptus Essential Oil (Eucalyptus globulus Labill.)
Euglena gracilisLD50: 0.05%
LD100: 0.09%
LD50: n.t
LD100: n.t
LD50: 0.8%
LD100: 1.1%
LD50: 0.5%
LD100: 1.1%
LD50: 0.6%
LD100: 1.3%
LD50: 0.5%
LD100: 0.9%
LD50: 0.5%
LD100: 0.7%
LD50: 0.1%
LD100: 0.2%
LD50: 0.1%
LD100: 0.3%
LD50: 0.5%
LD100: 0.1%
LD50: 0.1%
LD100: 0.2%
Gregarina blattarumLD50: n.t
LD100: n.t
LD50: 0.1%
LD100: 0.3%
LD50: 0.9%
LD100: 1.1%
LD50: 0.9%
LD100: 1.0%
LD50: 1.0%
LD100: 1.1%
LD50: 0.9%
LD100: 1.0%
LD50: 0.4%
LD100: 0.7%
LD50: 0.1%
LD100: 0.4%
LD50: 0.2%
LD100: 0.4%
LD50: 0.7%
LD100: 0.3%
LD50: 0.2%
LD100: 0.5%
Amoeba proteusLD50: 0.07%
LD100: 0.15%
LD50: 0.3%
LD100: 0.5%
LD50: 0.8%
LD100: 1.0%
LD50: 0.6%
LD100: 1.0%
LD50: 0.9%
LD100: 1.4%
LD50: 0.5%
LD100: 1.0%
LD50: 0.5%
LD100: 1.0%
LD50: 0.1%
LD100: 0.2%
LD50: 0.1%
LD100: 0.2%
LD50: 0.5%
LD100: 1.0%
LD50: 0.5%
LD100: 0.7%
Paramecium caudatumLD50: 0.001%
LD100: 0.006%
LD50: n.t
LD100: n.t
LD50: 1.0%
LD100: 1.3%
LD50: 0.8%
LD100: 1.2%
LD50: 1.0%
LD100: 1.5%
LD50: 0.8%
LD100: 1.2%
LD50: 0.8%
LD100: 1.2%
LD50: 0.3%
LD100: 0.5%
LD50: 0.3%
LD100: 0.5%
LD50: 0.8%
LD100: 1.2%
LD50: 0.1%
LD100: 0.3%
Pentatrichomonas hominisLD50: n.t
LD100: n.t
LD50: 0.05%
LD100: 0.14%
LD50: 1.0%
LD100: 1.5%
LD50: 0.8%
LD100: 1.0%
LD50: 0.9%
LD100: 1.3%
LD50: 0.8%
LD100: 1.0%
LD50: 0.9%
LD100: 1.1%
LD50: 0.1%
LD100: 0.3%
LD50: 0.2%
LD100: 0.4%
LD50: 0.9%
LD100: 1.1%
LD50: 0.1%
LD100: 0.3%
a—chloramphenicol, b—metronidazole, c—in rate 1:1:1, d—10% solution, e—10% solution, f—10% solution, g—5% solution, n.t—not tested.
Table 3. LD50, LD100 values for the tested mixtures of eucalyptus essential oil (Eucalyptus globulus Labill.) (E), organic acids (Acetic acid—A, Propionic acid—P, Lactic acid—L, Mixture of acids—M) and metal ion against selected protozoa.
Table 3. LD50, LD100 values for the tested mixtures of eucalyptus essential oil (Eucalyptus globulus Labill.) (E), organic acids (Acetic acid—A, Propionic acid—P, Lactic acid—L, Mixture of acids—M) and metal ion against selected protozoa.
ProtozoaEucalyptus Essential Oil (Eucalyptus globulus Labill.)
Acetic AcidPropionic AcidLactic AcidMixture of Acids a
Cu bMn cZn dCu bMn cZn dCu bMn cZn dCu bMn cZn d
EACuEAMnEAZnEPCuEPMnEPZnELCuELMnELZnEMCuEMMnEMZn
Euglena gracilis1LD50: 0.04% ± 0.035 ab
LD100: 0.08% ± 0.068 abc
LD50: 0.03% ± 0.032 ab
LD100: 0.06% ± 0.058 abcd
LD50: 0.03% ± 0.032 ab
LD100: 0.07% ± 0.065 abc
LD50: 0.01% ± 0.015 b
LD100: 0.03% ± 0.025 d
LD50: 0.04% ± 0.038 ab
LD100: 0.08% ± 0.078 a
LD50: 0.03% ± 0.028 ab
LD100: 0.06% ± 0.070 ab
LD50: 0.03% ± 0.032 ab
LD100: 0.07% ± 0.069 abc
LD50: 0.01% ± 0.102 a
LD100: 0.03% ± 0.032 bcd
LD50: 0.04% ± 0.038 ab
LD100: 0.08% ± 0.080 a
LD50: 0.03% ± 0.032 ab
LD100: 0.06% ± 0.088 a
LD50: 0.03% ± 0.028 ab
LD100: 0.07% ± 0.068 abc
LD50: 0.01% ± 0.102 a
LD100: 0.03% ± 0.030 cd
Gregarina blattarum1LD50: 0.04% ± 0.038 a LD100: 0.05% ± 0.045 bLD50: 0.03% ± 0.034 a
LD100: 0.07% ± 0.065 b
LD50: 0.03% ± 0.032 a
LD100: 0.06% ± 0.060 b
LD50: 0.03% ± 0.034 a
LD100: 0.04% ± 0.038 b
LD50: 0.04% ± 0.040 a
LD100: 0.05% ± 0.052 b
LD50: 0.03% ± 0.031 a
LD100: 0.07% ± 0.068 b
LD50: 0.03% ± 0.028 a
LD100: 0.06% ± 0.062 b
LD50: 0.03% ± 0.028 a
LD100: 0.04% ± 0.042 b
LD50: 0.04% ± 0.042 a
LD100: 0.05% ± 0.049 b
LD50: 0.03% ± 0.035 a
LD100: 0.07% ± 0.248 a
LD50: 0.03% ± 0.025 a
LD100: 0.06% ± 0.056 b
LD50: 0.03% ± 0.035 a
LD100: 0.04% ± 0.041 b
Amoeba proteus 1LD50: 0.03% ± 0.028 c
LD100: 0.06% ± 0.062 a
LD50: 0.04% ± 0.045 abc
LD100: 0.08% ± 0.076 a
LD50: 0.05% ± 0.052 abc
LD100: 0.09% ± 0.082 a
LD50: 0.07% ± 0.065 ab
LD100: 0.08% ± 0.075 a
LD50: 0.03% ± 0.032 c
LD100: 0.06% ± 0.062 a
LD50: 0.04% ± 0.042 bc
LD100: 0.08% ± 0.080 a
LD50: 0.05% ± 0.049 abc
LD100: 0.09% ± 0.085 a
LD50: 0.07% ± 0.072 a
LD100: 0.08% ± 0.082 a
LD50: 0.03% ± 0.031 c
LD100: 0.06% ± 0.055 a
LD50: 0.04% ± 0.045 abc
LD100: 0.08% ± 0.082 a
LD50: 0.05% ± 0.050 abc
LD100: 0.09% ± 0.078 a
LD50: 0.07% ± 0.070 ab
LD100: 0.08% ± 0.075 a
Paramecium caudatum 1LD50: 0.02% ± 0.020 a
LD100: 0.06% ± 0.062 a
LD50: 0.02% ± 0.022 a
LD100: 0.07% ± 0.070 a
LD50: 0.04% ± 0.040 a
LD100: 0.07% ± 0.072 a
LD50: 0.03% ± 0.032 a
LD100: 0.08% ± 0.075 a
LD50: 0.02% ± 0.022 a
LD100: 0.06% ± 0.062 a
LD50: 0.02% ± 0.022 a
LD100: 0.07% ± 0.072 a
LD50: 0.04% ± 0.042 a
LD100: 0.07% ± 0.071 a
LD50: 0.03% ± 0.032 a
LD100: 0.08% ± 0.075 a
LD50: 0.02% ± 0.024 a
LD100: 0.06% ± 0.065 a
LD50: 0.02% ± 0.024 a
LD100: 0.07% ± 0.069 a
LD50: 0.04% ± 0.032 a
LD100: 0.07% ± 0.065 a
LD50: 0.03% ± 0.032 a
LD100: 0.08% ± 0.078 a
Pentatrichomonas hominis1LD50: 0.04% ± 0.035 a
LD100: 0.07% ± 0.072 ab
LD50: 0.03% ± 0.032 a
LD100: 0.05% ± 0.045 b
LD50: 0.05% ± 0.050 a
LD100: 0.09% ± 0.085 ab
LD50: 0.03% ± 0.032 a
LD100: 0.04% ± 0.042 b
LD50: 0.04% ± 0.040 a
LD100: 0.07% ± 0.065 ab
LD50: 0.03% ± 0.030 a
LD100: 0.05% ± 0.050 b
LD50: 0.05% ± 0.045 a
LD100: 0.09% ± 0.085 ab
LD50: 0.03% ± 0.035 a
LD100: 0.04% ± 0.035 b
LD50: 0.04% ± 0.040 a
LD100: 0.07% ± 0.068 ab
LD50: 0.03% ± 0.048 a
LD100: 0.05% ± 0.052 b
LD50: 0.05% ± 0.024 a
LD100: 0.09% ± 0.125 a
LD50: 0.03% ± 0.052 a
LD100: 0.04% ± 0.040 b
1 Values followed by the same letter within a row are not significantly different (p > 0.05, Tukey’s test), a—in rate 1:1:1, b—10% solution, c—10% solution, d—10% solution, EACu, EAMn, EAZn—Eucalyptus essential oil (E) with acetic acid (A) and Cu, Mn, Zn ions, respectively; EPCu, EPMn, EPZn—Eucalyptus essential oil (E) with propionic acid (P) and Cu, Mn, Zn ions, respectively; ELCu, ELMn, ELZn—Eucalyptus essential oil (E) with lactic acid (L) and Cu, Mn, Zn ions, respectively; EMCu, EMMn, EMZn—Eucalyptus essential oil (E) with mixture of acids (M) and Cu, Mn, Zn ions, respectively.
Table 4. LD50, LD100 values of tea tree essential oil (Melaleuca alternifolia (Maiden & Betche) Cheel) and the components used in the study.
Table 4. LD50, LD100 values of tea tree essential oil (Melaleuca alternifolia (Maiden & Betche) Cheel) and the components used in the study.
ProtozoaCH aM bAcetic AcidPropionic AcidLactic AcidMixture of Acids cManganese (II) Chloride Solution dCopper (II) Carbonate Hydroxide Solution eZinc Carbonate Solution fCatalyst Solution gTea Tree Essential Oil
(Melaleuca alternifolia (Maiden & Betche) Cheel )
Euglena gracilisLD50: 0.05%
LD100: 0.09%
LD50: n.t
LD100: n.t
LD50: 0.8%
LD100: 1.1%
LD50: 0.5%
LD100: 1.1%
LD50: 0.6%
LD100: 1.3%
LD50: 0.5%
LD100: 0.9%
LD50: 0.5%
LD100: 0.7%
LD50: 0.1%
LD100: 0.2%
LD50: 0.1%
LD100: 0.3%
LD50: 0.5%
LD100: 0.1%
LD50: 0.05%
LD100: 0.1%
Gregarina blattarumLD50: n.t
LD100: n.t
LD50: 0.1%
LD100: 0.3%
LD50: 0.9%
LD100: 1.1%
LD50: 0.9%
LD100: 1.0%
LD50: 1.0%
LD100: 1.1%
LD50: 0.9%
LD100: 1.0%
LD50: 0.4%
LD100: 0.7%
LD50: 0.1%
LD100: 0.4%
LD50: 0.2%
LD100: 0.4%
LD50: 0.7%
LD100: 0.3%
LD50: 0.25%
LD100: 0.3%
Amoeba proteusLD50: 0.07%
LD100: 0.15%
LD50: 0.3%
LD100: 0.5%
LD50: 0.8%
LD100: 1.0%
LD50: 0.6%
LD100: 1.0%
LD50: 0.9%
LD100: 1.4%
LD50: 0.5%
LD100: 1.0%
LD50: 0.5%
LD100: 1.0%
LD50: 0.1%
LD100: 0.2%
LD50: 0.1%
LD100: 0.2%
LD50: 0.5%
LD100: 1.0%
LD50: 0.3%
LD100: 0.5%
Paramecium caudatumLD50: 0.001%
LD100: 0.006%
LD50: n.t
LD100: n.t
LD50: 1.0%
LD100: 1.3%
LD50: 0.8%
LD100: 1.2%
LD50: 1.0%
LD100: 1.5%
LD50: 0.8%
LD100: 1.2%
LD50: 0.8%
LD100: 1.2%
LD50: 0.3%
LD100: 0.5%
LD50: 0.3%
LD100: 0.5%
LD50: 0.8%
LD100: 1.2%
LD50: 0.2%
LD100: 0.25%
Pentatrichomonas hominisLD50: n.t
LD100: n.t
LD50: 0.05%
LD100: 0.14%
LD50: 1.0%
LD100: 1.5%
LD50: 0.8%
LD100: 1.0%
LD50: 0.9%
LD100: 1.3%
LD50: 0.8%
LD100: 1.0%
LD50: 0.9%
LD100: 1.1%
LD50: 0.1%
LD100: 0.3%
LD50: 0.2%
LD100: 0.4%
LD50: 0.9%
LD100: 1.1%
LD50: 0.08%
LD100: 0.1%
a—chloramphenicol, b—metronidazole, c—in rate 1:1:1, d—10% solution, e—10% solution, f—10% solution, g—5% solution, n.t—not tested.
Table 5. LD50, LD100 values of tea tree essential oil (Melaleuca alternifolia (Maiden & Betche) Cheel) (T), organic acids (Acetic acid—A, Propionic acid—P, Lactic acid—L, Mixture of acids—M) and metal ion against selected protozoa.
Table 5. LD50, LD100 values of tea tree essential oil (Melaleuca alternifolia (Maiden & Betche) Cheel) (T), organic acids (Acetic acid—A, Propionic acid—P, Lactic acid—L, Mixture of acids—M) and metal ion against selected protozoa.
ProtozoaTea Tree Essential Oil (Melaleuca alternifolia (Maiden & Betche) Cheel)
Acetic AcidPropionic AcidLactic AcidMixture of Acids a
Cu bMn cZn dCu bMn cZn dCu bMn cZn dCu bMn cZn d
TACuTAMnTAZnTPCuTPMnTPZnTLCuTLMnTLZnTMCuTMMnTMZn
Euglena gracilis1LD50: 0.03% ± 0.032 a
LD100: 0.06% ± 0.059 ab
LD50: 0.04% ± 0.035 a
LD100: 0.07% ± 0.065 a
LD50: 0.03% ±
LD100: 0.05% ± 0.052 abc
LD50: 0.03% ± 0.026 a
LD100: 0.04% ± 0.035 bcd
LD50: 0.01% ± 0.0134 ab
LD100: 0.02% ± 0.018 de
LD50: 0.02% ± 0.020 ab
LD100: 0.03% ± 0.028 cde
LD50: 0.02% ± 0.021 ab
LD100: 0.04% ± 0.038 bcd
LD50: 0.02% ± 0.022 ab
LD100: 0.04% ± 0.042 abcd
LD50: 0.02% ± 0.022 ab
LD100: 0.05% ± 0.052 abc
LD50: 0.001% ± 0.001 b
LD100: 0.003% ± 0.002 e
LD50: 0.001% ± 0.001 b
LD100: 0.002% ± 0.002 e
LD50: 0.003% ± 0.002 b
LD100: 0.004% ± 0.004 e
Gregarina blattarum1LD50: 0.04% ± 0.038 b
LD100: 0.07% ± 0.065 b
LD50: 0.04% ± 0.036 b
LD100: 0.05% ± 0.052 bcd
LD50: 0.04% ± 0.035 b
LD100: 0.06% ± 0.060 b
LD50: 0.04% ± 0.036 b
LD100: 0.06% ± 0.058 bc
LD50: 0.05% ± 0.048 b
LD100: 0.08% ± 0.078 b
LD50: 0.05% ± 0.051 b
LD100: 0.07% ± 0.068 b
LD50: 0.03% ± 0.031 b
LD100: 0.04% ± 0.038 bcd
LD50: 0.05% ± 0.049 b
LD100: 0.07% ± 0.065 b
LD50: 0.08% ± 0.075 a
LD100: 0.15% ± 0.138 a
LD50: 0.004% ± 0.004 c
LD100: 0.006% ± 0.006 d
LD50: 0.004% ± 0.004 c
LD100: 0.007% ± 0.007 cd
LD50: 0.003% ± 0.002 c
LD100: 0.005% ± 0.004 d
Amoeba proteus1LD50: 0.04% ± 0.038 bc
LD100: 0.06% ± 0.062 bc
LD50: 0.03% ± 0.035 cd
LD100: 0.06% ± 0.06 4 bc
LD50: 0.04% ± 0.042 bc
LD100: 0.07% ± 0.072 abc
LD50: 0.04% ± 0.042 bc
LD100: 0.07% ± 0.072 abc
LD50: 0.01% ± 0.014 de
LD100: 0.01% ± 0.014 de
LD50: 0.07% ± 0.072 a
LD100: 0.09% ± 0.092 a
LD50: 0.06% ± 0.058 ab
LD100: 0.08% ± 0.082 ab
LD50: 0.01% ± 0.012 e
LD100: 0.03% ± 0.028 d
LD50: 0.01% ± 0.016 de
LD100: 0.05% ± 0.052 c
LD50: 0.002% ± 0.002 e
LD100: 0.003% ± 0.004 de
LD50: 0.002% ± 0.002 e
LD100: 0.004% ± 0.003 e
LD50: 0.001% ± 0.001 e
LD100: 0.002% ± 0.002 e
Paramecium caudatum1LD50: 0.02% ± 0.022 abcd
LD100: 0.05% ± 0.052 bcd
LD50: 0.02% ± 0.020 abcd
LD100: 0.05% ± 0.045 cde
LD50: 0.03% ± 0.032 abcd
LD100: 0.06% ± 0.062 abc
LD50: 0.05% ± 0.045 ab
LD100: 0.08% ± 0.075 ab
LD50: 0.01% ± 0.012 bcd
LD100: 0.02% ± 0.022 ef
LD50: 0.05% ± 0.050 a
LD100: 0.09% ± 0.085 a
LD50: 0.05% ± 0.049 a
LD100: 0.07% ± 0.068 abc
LD50: 0.03% ± 0.035 abc
LD100: 0.04% ± 0.042 cde
LD50: 0.02% ± 0.024 abcd
LD100: 0.03% ± 0.032 de
LD50: 0.002% ± 0.002 cd
LD100: 0.005% ±
0.005 f
LD50: 0.001% ± 0.001 d
LD100: 0.002% ± 0.002 f
LD50: 0.003% ± 0.003 cd
LD100: 0.005% ± 0.005 f
Pentatrichomonas hominis1LD50: 0.09% ± 0.085 a
LD100: 0.35% ± 0.362 a
LD50: 0.08% ± 0.075 a
LD100: 0.2% ± 0.238 a
LD50: 0.07% ± 0.065 ab
LD100: 0.25% ± 0.238 a
LD50: 0.03% ± 0.032 cd
LD100: 0.05% ± 0.045 b
LD50: 0.01% ± 0.012 de
LD100: 0.04% ± 0.035 b
LD50: 0.07% ± 0.065 ab
LD100: 0.09% ± 0.088 b
LD50: 0.025% ± 0.025 cde
LD100: 0.045% ± 0.046 b
LD50: 0.05% ± 0.045 bc
LD100: 0.07% ± 0.072 b
LD50: 0.02% ± 0.020 cde
LD100: 0.05% ± 0.045 b
LD50: 0.004% ± 0.004 e
LD100: 0.004% ± 0.004 b
LD50: 0.007% ± 0.007 de
LD100: 0.009% ± 0.008 b
LD50: 0.002% ± 0.002 e
LD100: 0.004% ± 0.002 b
1 Values followed by the same letter within a row are not significantly different (p > 0.05, Tukey’s test), a—in rate 1:1:1, b—10% solution, c—10% solution, d—10% solution, TACu, TAMn, TAZn—Tea tree essential oil (T) with acetic acid (A) and Cu, Mn, Zn ions, respectively; TPCu, TPMn, TPZn—Tea tree essential oil (T) with propionic acid (P) and Cu, Mn, Zn ions, respectively; TLCu, TLMn, TLZn—Tea tree essential oil (T) with lactic acid (L) and Cu, Mn, Zn ions, respectively; TMCu, TMMn, TMZn—Tea tree essential oil (T) with mixture of acids (M) and Cu, Mn, Zn ions, respectively.
Table 6. LD50, LD100 values of cedar essential oil (Cedrus sp.) and the components used in the study.
Table 6. LD50, LD100 values of cedar essential oil (Cedrus sp.) and the components used in the study.
ProtozoaCH aM bAcetic AcidPropionic AcidLactic AcidMixture of Acids cManganese (II) Chloride Solution dCopper (II) Carbonate Hydroxide Solution eZinc Carbonate Solution fCatalyst Solution gCedar Essential Oil (Cedrus sp.)
Euglena gracilisLD50: 0.05%
LD100: 0.09%
LD50: n.t
LD100: n.t
LD50: 0.8%
LD100: 1.1%
LD50: 0.5%
LD100: 1.1%
LD50: 0.6%
LD100: 1.3%
LD50: 0.5%
LD100: 0.9%
LD50: 0.5%
LD100: 0.7%
LD50: 0.1%
LD100: 0.2%
LD50: 0.1%
LD100: 0.3%
LD50: 0.5%
LD100: 0.1%
LD50: 0.7%
LD100: 0.9%
Gregarina blattarumLD50: n.t
LD100: n.t
LD50: 0.1%
LD100: 0.3%
LD50: 0.9%
LD100: 1.1%
LD50: 0.9%
LD100: 1.0%
LD50: 1.0%
LD100: 1.1%
LD50: 0.9%
LD100: 1.0%
LD50: 0.4%
LD100: 0.7%
LD50: 0.1%
LD100: 0.4%
LD50: 0.2%
LD100: 0.4%
LD50: 0.7%
LD100: 0.3%
LD50: 0.7%
LD100: 0.9%
Amoeba proteusLD50: 0.07%
LD100: 0.15%
LD50: 0.3%
LD100: 0.5%
LD50: 0.8%
LD100: 1.0%
LD50: 0.6%
LD100: 1.0%
LD50: 0.9%
LD100: 1.4%
LD50: 0.5%
LD100: 1.0%
LD50: 0.5%
LD100: 1.0%
LD50: 0.1%
LD100: 0.2%
LD50: 0.1%
LD100: 0.2%
LD50: 0.5%
LD100: 1.0%
LD50: 0.4%
LD100: 0.6%
Paramecium caudatumLD50: 0.001%
LD100: 0.006%
LD50: n.t
LD100: n.t
LD50: 1.0%
LD100: 1.3%
LD50: 0.8%
LD100: 1.2%
LD50: 1.0%
LD100: 1.5%
LD50: 0.8%
LD100: 1.2%
LD50: 0.8%
LD100: 1.2%
LD50: 0.3%
LD100: 0.5%
LD50: 0.3%
LD100: 0.5%
LD50: 0.8%
LD100: 1.2%
LD50: 0.1%
LD100: 0.25%
Pentatrichomonas hominisLD50: n.t
LD100: n.t
LD50: 0.05%
LD100: 0.14%
LD50: 1.0%
LD100: 1.5%
LD50: 0.8%
LD100: 1.0%
LD50: 0.9%
LD100: 1.3%
LD50: 0.8%
LD100: 1.0%
LD50: 0.9%
LD100: 1.1%
LD50: 0.1%
LD100: 0.3%
LD50: 0.2%
LD100: 0.4%
LD50: 0.9%
LD100: 1.1%
LD50: 0.1%
LD100: 0.2%
a—chloramphenicol, b—metronidazole, c—in rate 1:1:1, d—10% solution, e—10% solution, f—10% solution, g—5% solution, n.t—not tested.
Table 7. LD50, LD100 values of cedar essential oil (Cedrus sp.) (C), organic acids (Acetic acid—A, Propionic acid—P, Lactic acid—L, Mixture of acids—M) and metal ion against selected protozoa.
Table 7. LD50, LD100 values of cedar essential oil (Cedrus sp.) (C), organic acids (Acetic acid—A, Propionic acid—P, Lactic acid—L, Mixture of acids—M) and metal ion against selected protozoa.
ProtozoaCedar Essential Oil (Cedrus sp.)
Acetic AcidPropionic AcidLactic AcidMixture of Acids a
Cu bMn cZn dCu bMn cZn dCu bMn cZn dCu bMn cZn d
CACuCAMnCAZnCPCuCPMnCPZnCLCuCLMnCLZnCMCuCMMnCMZn
Euglena gracilis1LD50: 0.04% ± 0.035 a
LD100: 0.08% ± 0.079 a
LD50: 0.03% ± 0.033 a
LD100: 0.07% ± 0.065 abc
LD50: 0.04% ± 0.035 a
LD100: 0.07% ± 0.068 ab
LD50: 0.03% ± 0.026 a
LD100: 0.05% ± 0.048 bcd
LD50: 0.01% ± 0.014 ab
LD100: 0.02% ± 0.018 fg
LD50: 0.02% ± 0.020 ab
LD100: 0.03% ± 0.028 def
LD50: 0.01% ± 0.014 ab
LD100: 0.02% ± 0.023 efg
LD50: 0.02% ± 0.023 ab
LD100: 0.04% ± 0.043 cde
LD50: 0.03% ± 0.025 a
LD100: 0.06% ± 0.055 bc
LD50: 0.001% ± 0.001 b
LD100: 0.002% ± 0.002 g
LD50: 0.002% ± 0.002 b
LD100: 0.004% ± 0.004 g
LD50: 0.003% ± 0.003 b
LD100: 0.006% ± 0.007 fg
Gregarina blattarum 1LD50: 0.03% ± 0.032 a
LD100: 0.06% ±
0.062 abc
LD50: 0.02% ± 0.022 ab
LD100: 0.05% ±
0.052 bc
LD50: 0.04% ± 0.035 a LD100: 0.08% ±
0.082 a
LD50: 0.03% ± 0.034 a
LD100: 0.04% ± 0.042 c
LD50: 0.03% ± 0.033 a
LD100: 0.07% ± 0.070 ab
LD50: 0.03% ± 0.031 a
LD100: 0.05% ±
0.052 bc
LD50: 0.03% ± 0.031 a
LD100: 0.04% ± 0.038 c
LD50: 0.02% ± 0.022 ab
LD100: 0.05% ± 0.049 bc
LD50: 0.04% ± 0.043 a
LD100: 0.05% ±
0.045 bc
LD50: 0.003% ± 0.003 b
LD100: 0.004% ± 0.004 d
LD50: 0.002% ± 0.002 b
LD100: 0.005% ± 0.005 d
LD50: 0.004% ± 0.004 b
LD100: 0.005% ± 0.005 d
Amoeba proteus1LD50: 0.04% ± 0.038 ab
LD100: 0.05% ± 0.052 b
LD50: 0.05% ± 0.052 a
LD100: 0.08% ± 0.076 ab
LD50: 0.06% ± 0.062 a
LD100: 0.01% ± 0.014 c
LD50: 0.05% ± 0.045 ab
LD100: 0.07% ± 0.072 ab
LD50: 0.05% ± 0.045 ab
LD100: 0.08% ± 0.078 ab
LD50: 0.04% ± 0.038 ab
LD100: 0.06% ± 0.058 ab
LD50: 0.06% ± 0.058 a
LD100: 0.08% ± 0.082 a
LD50: 0.05% ± 0.045 ab
LD100: 0.07% ± 0.072 ab
LD50: 0.02% ± 0.019 bc
LD100: 0.05% ± 0.052 b
LD50: 0.006% ± 0.006 c LD100: 0.008% ± 0.008 cLD50: 0.005% ± 0.005 c
LD100: 0.007% ± 0.007 c
LD50: 0.002% ± 0.002 c
LD100: 0.005% ± 0.005 c
Paramecium caudatum1LD50: 0.03% ± 0.025 ab LD100: 0.08% ± 0.082 aLD50: 0.04% ± 0.040 a
LD100: 0.07% ± 0.072 a
LD50: 0.05% ±
0.048 a
LD100: 0.08% ± 0.075 a
LD50: 0.04% ± 0.042 a
LD100: 0.08% ± 0.075 a
LD50: 0.04% ± 0.042 a
LD100: 0.06% ± 0.060 abc
LD50: 0.04% ± 0.040 a
LD100: 0.07% ± 0.068 ab
LD50: 0.03% ± 0.030 ab
LD100: 0.04% ± 0.042 bc
LD50: 0.03% ± 0.035 a
LD100: 0.08% ± 0.078 a
LD50: 0.02% ± 0.024 ab
LD100: 0.04% ± 0.035 cd
LD50: 0.003% ± 0.002 b
LD100: 0.004% ± 0.004 e
LD50: 0.003% ± 0.002 b LD100: 0.008% ± 0.008 deLD50: 0.002% ± 0.002 b
LD100: 0.004% ± 0.004 e
Pentatrichomonas hominis1LD50: 0.09% ± 0.085 a
LD100: 0.15% ± 0.150 a
LD50: 0.02% ± 0.020 bc
LD100: 0.04% ± 0.042 bcde
LD50: 0.04% ± 0.040 b
LD100: 0.07% ± 0.072 b
LD50: 0.04% ± 0.035 b
LD100: 0.06% ± 0.058 bc
LD50: 0.03% ± 0.025 bc
LD100: 0.04% ± 0.040 bcde
LD50: 0.03% ± 0.025 bc
LD100: 0.05% ± 0.048 bcd
LD50: 0.03% ± 0.032 b
LD100: 0.04% ±
0.042 bcde
LD50: 0.02% ± 0.022 bc
LD100: 0.03% ± 0.025 cde
LD50: 0.025% ± 0.026 bc
LD100: 0.07% ± 0.068 b
LD50: 0.003% ± 0.002 c
LD100: 0.004% ± 0.004 e
LD50: 0.002% ± 0.002 c LD100: 0.003% ± 0.002 eLD50: 0.002% ± 0.002 c LD100: 0.007% ± 0.006 de
1 Values followed by the same letter within a row are not significantly different (p > 0.05, Tukey’s test), a—in rate 1:1:1, b—10% solution, c—10% solution, d—10% solution; CACu, CAMn, CAZn—Cedar essential oil (C) with acetic acid (A) and Cu, Mn, Zn ions, respectively; CPCu, CPMn, CPZn—Cedar essential oil (C) with propionic acid (P) and Cu, Mn, Zn ions, respectively; CLCu, CLMn, CLZn—Cedar essential oil (C) with lactic acid (L) and Cu, Mn, Zn ions, respectively; CMCu, CMMn, CMZn—Cedar essential oil (C) with mixture of acids (M) and Cu, Mn, Zn ions, respectively.
Table 8. LD50, LD100 values of lavender essential oil (Lavandula angustifolia Miller) and the components used in the study.
Table 8. LD50, LD100 values of lavender essential oil (Lavandula angustifolia Miller) and the components used in the study.
ProtozoaCH aM bAcetic AcidPropionic AcidLactic AcidMixture of Acids cManganese (II) Chloride Solution dCopper (II) Carbonate Hydroxide Solution eZinc Carbonate Solution fCatalyst Solution gLavender Essential Oil (Lavandula angustifolia Miller)
Euglena gracilisLD50: 0.05%
LD100: 0.09%
LD50: n.t
LD100: n.t
LD50: 0.8%
LD100: 1.1%
LD50: 0.5%
LD100: 1.1%
LD50: 0.6%
LD100: 1.3%
LD50: 0.5%
LD100: 0.9%
LD50: 0.5%
LD100: 0.7%
LD50: 0.1%
LD100: 0.2%
LD50: 0.1%
LD100: 0.3%
LD50: 0.5%
LD100: 0.1%
LD50: 0.8%
LD100: 0.9%
Gregarina blattarumLD50: n.t
LD100: n.t
LD50: 0.1%
LD100: 0.3%
LD50: 0.9%
LD100: 1.1%
LD50: 0.9%
LD100: 1.0%
LD50: 1.0%
LD100: 1.1%
LD50: 0.9%
LD100: 1.0%
LD50: 0.4%
LD100: 0.7%
LD50: 0.1%
LD100: 0.4%
LD50: 0.2%
LD100: 0.4%
LD50: 0.7%
LD100: 0.3%
LD50: 0.7%
LD100: 0.8%
Amoeba proteusLD50: 0.07%
LD100: 0.15%
LD50: 0.3%
LD100: 0.5%
LD50: 0.8%
LD100: 1.0%
LD50: 0.6%
LD100: 1.0%
LD50: 0.9%
LD100: 1.4%
LD50: 0.5%
LD100: 1.0%
LD50: 0.5%
LD100: 1.0%
LD50: 0.1%
LD100: 0.2%
LD50: 0.1%
LD100: 0.2%
LD50: 0.5%
LD100: 1.0%
LD50: 0.5%
LD100: 0.8%
Paramecium caudatumLD50: 0.001%
LD100: 0.006%
LD50: n.t
LD100: n.t
LD50: 1.0%
LD100: 1.3%
LD50: 0.8%
LD100: 1.2%
LD50: 1.0%
LD100: 1.5%
LD50: 0.8%
LD100: 1.2%
LD50: 0.8%
LD100: 1.2%
LD50: 0.3%
LD100: 0.5%
LD50: 0.3%
LD100: 0.5%
LD50: 0.8%
LD100: 1.2%
LD50: 0.1%
LD100: 0.25%
Pentatrichomonas hominisLD50: n.t
LD100: n.t
LD50: 0.05%
LD100: 0.14%
LD50: 1.0%
LD100: 1.5%
LD50: 0.8%
LD100: 1.0%
LD50: 0.9%
LD100: 1.3%
LD50: 0.8%
LD100: 1.0%
LD50: 0.9%
LD100: 1.1%
LD50: 0.1%
LD100: 0.3%
LD50: 0.2%
LD100: 0.4%
LD50: 0.9%
LD100: 1.1%
LD50: 0.2%
LD100: 0.4%
a—chloramphenicol, b—metronidazole, c—in rate 1:1:1, d—10% solution, e—10% solution, f—10% solution, g—5% solution, n.t–not tested.
Table 9. LD50, LD100 values of lavender essential oil (Lavandula angustifolia Miller) (L), organic acids (Acetic acid—A, Propionic acid—P, Lactic acid—L, Mixture of acids—M) and metal ion against selected protozoal.
Table 9. LD50, LD100 values of lavender essential oil (Lavandula angustifolia Miller) (L), organic acids (Acetic acid—A, Propionic acid—P, Lactic acid—L, Mixture of acids—M) and metal ion against selected protozoal.
ProtozoaLavender Essential Oil (Lavandula angustifolia Miller)
Acetic AcidPropionic AcidLactic AcidMixture of Acids a
Cu bMn cZn dCu bMn cZn dCu bMn cZn dCu bMn cZn d
LACuLAMnLAZnLPCuLPMnLPZnLLCuLLMnLLZnLMCuLMMnLMZn
Euglena gracilis1LD50: 0.04% ± 0.035 ab
LD100: 0.06% ± ±
0.059 ab
LD50: 0.02% ± 0.024 bcd
LD100: 0.04% ±
0.035 cd
LD50: 0.05% ± 0.045 a
LD100: 0.08% ±
0.078 a
LD50: 0.03% ± 0.026 abc
LD100: 0.045% ± 0.046 bcd
LD50: 0.01% ± 0.014 cde
LD100: 0.03% ± 0.025 de
LD50: 0.03% ± 0.028 abc
LD100: 0.05% ± 0.050 bc
LD50: 0.02% ± 0.016 bcde
LD100: 0.04% ± 0.042 bcd
LD50: 0.03% ± 0.025 abc
LD100: 0.05% ±
0.045 bcd
LD50: 0.03% ± 0.025 abc
LD100: 0.05% ±
0.052 bc
LD50: 0.002% ± 0.002 e
LD100: 0.004% ± 0.004 e
LD50: 0.001% ± 0.001 e
LD100: 0.005% ± 0.004 e
LD50: 0.004% ± 0.004 de
LD100: 0.006% ± 0.006 e
Gregarina blattarum1LD50: 0.03% ± 0.032 abc
LD100: 0.06% ±
0.062 ab
LD50: 0.01% ± 0.011 cd
LD100: 0.04% ±
0.040 b
LD50: 0.03% ± 0.032 abc
LD100: 0.08% ±
0.082 a
LD50: 0.03% ±
0.034 ab
LD100: 0.045% ±
0.044 b
LD50: 0.03% ±
0.032 abc
LD100: 0.06% ±
0.060 ab
LD50: 0.04% ±
0.036 ab
LD100: 0.05% ±
0.052 b
LD50: 0.05% ± 0.049 a
LD100: 0.07% ±
0.065 ab
LD50: 0.02% ± 0.022 bcd
LD100: 0.04% ±
0.042 b
LD50: 0.05% ± 0.045 a
LD100: 0.09% ±
0.085 a
LD50: 0.003% ± 0.003 d
LD100: 0.004% ±
0.004 c
LD50: 0.002% ± 0.002 d
LD100: 0.005% ±
0.005 c
LD50: 0.004% ± 0.004 d
LD100: 0.006% ±
0.006 c
Amoeba proteus1LD50: 0.05% ±
0.052 ab
LD100: 0.06% ±
0.055 b
LD50: 0.05% ±
0.052 ab
LD100: 0.07% ±
0.074 ab
LD50: 0.06% ±
0.062 a
LD100: 0.09% ±
0.085 a
LD50: 0.04% ±
0.042 abc
LD100: 0.06% ±
0.060 ab
LD50: 0.05% ±
0.045 ab
LD100: 0.07% ±
0.070 ab
LD50: 0.04% ±
0.038 abc
LD100: 0.07% ±
0.068 ab
LD50: 0.02% ±
0.016 cd
LD100: 0.05% ±
0.049 b
LD50: 0.04% ±
0.042 abc
LD100: 0.07% ±
0.072 ab
LD50: 0.03% ±
0.026 bcd
LD100: 0.06% ±
0.055 b
LD50: 0.003% ±
0.003 d
LD100: 0.004% ± 0.004 c
LD50: 0.002% ±
0.002 d
LD100: 0.004% ± 0.004 c
LD50: 0.003% ±
0.002 d
LD100: 0.005% ± 0.005 c
Paramecium caudatum1LD50: 0.05% ± 0.050 a
LD100: 0.08% ± 0.082 a
LD50: 0.05% ± 0.048 ab
LD100: 0.08% ± 0.075 a
LD50: 0.03% ± 0.032 abc
LD100: 0.07% ±
0.072 a
LD50: 0.05% ± 0.045 ab
LD100: 0.08% ± 0.075 a
LD50: 0.03% ± 0.032 abc
LD100: 0.06% ± 0.060 ab
LD50: 0.03% ± 0.030 bc
LD100: 0.08% ± 0.080 a
LD50: 0.02% ± 0.018 cd
LD100: 0.04% ± 0.042 b
LD50: 0.04% ± 0.039 ab
LD100: 0.07% ± 0.072 a
LD50: 0.04% ± 0.035 abc
LD100: 0.06% ± 0.062 ab
LD50: 0.006% ± 0.006 d
LD100: 0.008% ± 0.008 c
LD50: 0.005% ± 0.005 d
LD100: 0.008% ± 0.008 c
LD50: 0.004% ± 0.004 d
LD100: 0.006% ± 0.006 c
Pentatrichomonas hominis1LD50: 0.07% ± 0.070 ab
LD100: 0.1% ± 0.125 a
LD50: 0.07% ± 0.072 ab
LD100: 0.09% ± 0.085 bc
LD50: 0.06% ± 0.040 cd
LD100: 0.08% ± 0.075 bc
LD50: 0.08% ± 0.075 ab
LD100: 0.1% ± 0.098 abc
LD50: 0.06% ± 0.025 de
LD100: 0.09% ± 0.092 abc
LD50: 0.08% ± 0.080 a
LD100: 0.1% ± 0.110 ab
LD50: 0.05% ±
0.048 bcd
LD100: 0.07% ± 0.072 c
LD50: 0.08% ± 0.075 ab
LD100: 0.1% ± 0.110 ab
LD50: 0.055% ± 0.054 abc
LD100: 0.09% ± 0.088 bc
LD50: 0.003% ± 0.002 e LD100: 0.005% ± 0.005 dLD50: 0.003% ± 0.002 e
LD100: 0.007% ± 0.006 d
LD50: 0.004% ± 0.004 e
LD100: 0.008% ± 0.008 d
1 Values followed by the same letter within a row are not significantly different (p > 0.05, Tukey’s test), a—in rate 1:1:1, b—10% solution, c—10% solution, d—10% solution; LACu, LAMn, LAZn—Lavender essential oil (L) with acetic acid (A) and Cu, Mn, Zn ions, respectively; LPCu, LPMn, LPZn—Lavender essential oil (L) with propionic acid (P) and Cu, Mn, Zn ions, respectively; LLCu, LLMn, LLZn—Lavender essential oil (L) with lactic acid (L) and Cu, Mn, Zn ions, respectively; LMCu, LMMn, LMZn—Lavender essential oil (L) with mixture of acids (M) and Cu, Mn, Zn ions, respectively.
Table 10. The most efficient combination against tested protozoan.
Table 10. The most efficient combination against tested protozoan.
ProtozoaLD50LD100:
Euglena gracilisTMCu, TMMN, CMCu, LMMnTMMn, CMCu
Gregarina blattarumCMMn, LMMnCMCu, LMCu
Amoeba proteusTMZnTMZn
Paramecium caudatumTMMnTMMn
Pentatrichomonas hominisTMZn, CMMn, CMZnCMMn
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Iwiński, H.; Łyczko, J.; Różański, H.; Szumny, A. Novel Formula of Antiprotozoal Mixtures. Antibiotics 2022, 11, 913. https://doi.org/10.3390/antibiotics11070913

AMA Style

Iwiński H, Łyczko J, Różański H, Szumny A. Novel Formula of Antiprotozoal Mixtures. Antibiotics. 2022; 11(7):913. https://doi.org/10.3390/antibiotics11070913

Chicago/Turabian Style

Iwiński, Hubert, Jacek Łyczko, Henryk Różański, and Antoni Szumny. 2022. "Novel Formula of Antiprotozoal Mixtures" Antibiotics 11, no. 7: 913. https://doi.org/10.3390/antibiotics11070913

APA Style

Iwiński, H., Łyczko, J., Różański, H., & Szumny, A. (2022). Novel Formula of Antiprotozoal Mixtures. Antibiotics, 11(7), 913. https://doi.org/10.3390/antibiotics11070913

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop